174 related articles for article (PubMed ID: 37273877)
1. Cumulative non-high-density lipoprotein cholesterol burden and risk of atherosclerotic cardiovascular disease: a prospective community-based study.
Guan XM; Shi HP; Xu S; Chen Y; Zhang RF; Dong YX; Gao LJ; Wu SL; Xia YL
Front Cardiovasc Med; 2023; 10():1105342. PubMed ID: 37273877
[TBL] [Abstract][Full Text] [Related]
2. The association between low-density and non-high-density lipoprotein cholesterol with incident cardiovascular disease among low-risk Iranians during 2 decades follow-up.
Tohidi M; Asgari S; Chary A; Azizi F; Hadaegh F
Clin Biochem; 2022; 109-110():28-36. PubMed ID: 35970222
[TBL] [Abstract][Full Text] [Related]
3. Association of total cholesterol, low-density lipoprotein cholesterol, and non-high-density lipoprotein cholesterol with atherosclerotic cardiovascular disease and cancer in a Chinese male population.
Guan XM; Wu SL; Yang XL; Han X; Yang YH; Li XT; Bin Waleed K; Yue Du ; Zhan SY; Liu Y; Li HH; Xia YL
Int J Cancer; 2018 Mar; 142(6):1209-1217. PubMed ID: 29119548
[TBL] [Abstract][Full Text] [Related]
4. Trajectories of Blood Lipid Concentrations Over the Adult Life Course and Risk of Cardiovascular Disease and All-Cause Mortality: Observations From the Framingham Study Over 35 Years.
Duncan MS; Vasan RS; Xanthakis V
J Am Heart Assoc; 2019 Jun; 8(11):e011433. PubMed ID: 31137992
[TBL] [Abstract][Full Text] [Related]
5. Determinants of incident atherosclerotic cardiovascular disease events among individuals with type 2 diabetic microvascular complications in the UK: a prospective cohort study.
Wang Y; Bulloch G; Huang Y; Liang Y; Du Z; Wu G; Fang Y; Hu Y; Shang X; Zhu Z; Zhang X; Yang X; Yu H
Diabetol Metab Syndr; 2023 Aug; 15(1):178. PubMed ID: 37644580
[TBL] [Abstract][Full Text] [Related]
6. Cumulative remnant cholesterol predicts cardiovascular outcomes in elderly patients with atherosclerotic cardiovascular disease.
Xiao Z; Lin Z; Xu L; Xu W; Huang H; Wang Y; Cao S; Xie Z; Liao W; Liao Y; Bin J; Feng W; Chen Y
Eur J Prev Cardiol; 2023 Nov; 30(17):1924-1934. PubMed ID: 37708385
[TBL] [Abstract][Full Text] [Related]
7. Inverted U-Shaped Association of Plasma Resolvin D2 With Atherosclerotic Cardiovascular Disease and the Mediation Effects of Serum Cholesterol: A Chinese Community-Based Study.
Liu B; Zhang J; Zhang K; Li M; Jing Y; Gu S; Ding H; Liang Y; Zhou H; Dong C
J Am Heart Assoc; 2024 Mar; 13(5):e032588. PubMed ID: 38420767
[TBL] [Abstract][Full Text] [Related]
8. Non-HDL cholesterol and residual risk of cardiovascular events in patients with ischemic heart disease and well-controlled LDL cholesterol: a cohort study.
Hansen MK; Mortensen MB; Warnakula Olesen KK; Thrane PG; Maeng M
Lancet Reg Health Eur; 2024 Jan; 36():100774. PubMed ID: 38019978
[TBL] [Abstract][Full Text] [Related]
9. Associations of LDL Cholesterol, Non-HDL Cholesterol, and Apolipoprotein B With Cardiovascular Disease Occurrence in Adults: Korean Genome and Epidemiology Study.
Yun SY; Rim JH; Kang H; Lee SG; Lim JB
Ann Lab Med; 2023 May; 43(3):237-243. PubMed ID: 36544335
[TBL] [Abstract][Full Text] [Related]
10. Risk of Incident Atherosclerotic Cardiovascular DiseaseEvents by Achieved Atherogenic Lipid Levels Among62,428 Statin-Treated Individuals With Diabetes Mellitus.
Rana JS; Liu JY; Moffet HH; Boklage SH; Khan I; Karter AJ
Am J Cardiol; 2018 Sep; 122(5):762-767. PubMed ID: 30057224
[TBL] [Abstract][Full Text] [Related]
11. Cumulative burden of lipid profiles predict future incidence of ischaemic stroke and residual risk.
Dai L; Xu J; Zhang Y; Wang A; Chen Z; Mo J; Li H; Meng X; Wu S; Wang Y
Stroke Vasc Neurol; 2021 Dec; 6(4):581-588. PubMed ID: 33827914
[TBL] [Abstract][Full Text] [Related]
12. Non-HDL cholesterol and residual cardiovascular risk in statin-treated patients with and without diabetes: The Western Denmark Heart Registry.
Hansen MK; Mortensen MB; Olesen KKW; Thrane PG; Thomsen RW; Maeng M
Eur J Prev Cardiol; 2024 Mar; ():. PubMed ID: 38513361
[TBL] [Abstract][Full Text] [Related]
13. Triglyceride to high-density lipoprotein cholesterol ratio and risk of atherosclerotic cardiovascular disease in a Chinese population.
Zhou L; Mai J; Li Y; Guo M; Wu Y; Gao X; Wu Y; Liu X; Zhao L
Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1706-1713. PubMed ID: 32811737
[TBL] [Abstract][Full Text] [Related]
14. Increased triglyceride/high-density lipoprotein cholesterol ratio may be associated with reduction in the low-density lipoprotein particle size: assessment of atherosclerotic cardiovascular disease risk.
Yokoyama K; Tani S; Matsuo R; Matsumoto N
Heart Vessels; 2019 Feb; 34(2):227-236. PubMed ID: 30140959
[TBL] [Abstract][Full Text] [Related]
15. Association between remnant lipoprotein cholesterol, high-sensitivity C-reactive protein, and risk of atherosclerotic cardiovascular disease events in the Multi-Ethnic Study of Atherosclerosis (MESA).
Chevli PA; Islam T; Pokharel Y; Rodriguez F; Virani SS; Blaha MJ; Bertoni AG; Budoff M; Otvos JD; Shapiro MD
J Clin Lipidol; 2022; 16(6):870-877. PubMed ID: 36180367
[TBL] [Abstract][Full Text] [Related]
16. Association between plasma maresin 1 and the risk of atherosclerotic cardiovascular disease in Chinese adults: A community-based cohort study.
Li M; Sun Y; Liu B; Xue Y; Zhu M; Zhang K; Jing Y; Ding H; Liang Y; Zhou H; Dong C
Nutr Metab Cardiovasc Dis; 2024 Jul; 34(7):1631-1638. PubMed ID: 38653673
[TBL] [Abstract][Full Text] [Related]
17. The Yin and Yang of High-density Lipoprotein and Atherosclerotic Cardiovascular Disease: Focusing on Functionality and Cholesterol Efflux to Reframe the HDL Hypothesis.
Ganjali S; Watts GF; Banach M; Reiner Ž; Nachtigal P; Sahebkar A
Curr Med Chem; 2021; 28(29):6066-6081. PubMed ID: 33563147
[TBL] [Abstract][Full Text] [Related]
18. High-Sensitivity C-Reactive Protein Discordance With Atherogenic Lipid Measures and Incidence of Atherosclerotic Cardiovascular Disease in Primary Prevention: The ARIC Study.
Quispe R; Michos ED; Martin SS; Puri R; Toth PP; Al Suwaidi J; Banach M; Virani SS; Blumenthal RS; Jones SR; Elshazly MB
J Am Heart Assoc; 2020 Feb; 9(3):e013600. PubMed ID: 32013698
[TBL] [Abstract][Full Text] [Related]
19. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
Rosenblit PD
Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
[TBL] [Abstract][Full Text] [Related]
20. Small Dense Low-Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study.
Ikezaki H; Lim E; Cupples LA; Liu CT; Asztalos BF; Schaefer EJ
J Am Heart Assoc; 2021 Feb; 10(5):e019140. PubMed ID: 33586462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
